User menu

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Bibliographic reference MARINA, NM ; SMELAND, S ; BIELACK, SS ; BERNSTEIL, M ; JOVIC, G ; et. al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.. In: The Lancet Oncology, Vol. 25 (2016)
Permanent URL http://hdl.handle.net/2078.1/176473